Potential new mRNA-based therapy for pre-eclampsia

Lipid nanoparticles targeting VEGF mRNA show promise in treating pre-eclampsia, restoring maternal blood pressure and enhancing fetal health in murine models.

Psychedelic Research Pioneer Roland Griffiths Passes At Age 77

A sad day in the psychedelics community today as news filters out that leading industry neuroscientist, Dr. Roland Griffiths, Ph.D., has passed. The esteemed Johns

October 17, 2023

EASEE® receives a “Shark Tank” innovation award from the Epilepsy Foundation – Biotech Investments

Issuer: PRECISIS GmbH / Key word(s): Miscellaneous 20.07.2023 / 15:26 CET/CEST The issuer is solely responsible for the content of this announcement. 26 June 2023:

July 21, 2023

Boehringer and CBmed partner to develop cancer therapies

Share this article The new partnership is expected to expedite and widen the oncology portfolio of Boehringer. Credit: nitpicker/ Shutterstock.com. Boehringer Ingelheim has entered a

February 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.